FKA‐A NPs enhances PTX‐A NPs efficacy to suppress ovarian cancer via regulating Skp2/YAP pathway

Recurrence and distant metastasis after paclitaxel (PTX)‐based chemotherapy in ovarian cancer (OC) patients remains a clinical obstacle. Flavokawain A (FKA) is a novel chalcone from kava plant that can induce G2/M arrest and inhibit invasion and metastasis in different tumor cells. In this study, we examined the effects and the molecular mechanism of sodium aescinate (Aes)‐stabilized nanoparticles FKA‐A NPs in enhancing the efficacy of PTX‐A NPs in vitro and in vivo. We showed that FKA‐A NPs combined with PTX‐A NPs notably inhibited the proliferation and migration and reduced the expression of EMT‐related markers in OCs. YAP nuclear translocation and its downstream signaling pathway were remarkably activated after PTX‐A NPs treatment in OCs. FKA‐A NPs obviously inhibited YAP nuclear translocation and reduced the transcriptional activity of YAP target genes. Simultaneously, FKA‐A NPs dose and time dependently inhibited Skp2 expression in A2780 and Skov3 cells. In contrast, overexpression of Skp2 significantly attenuated the inhibition of FKA‐A NPs on YAP nuclear translocation. In OC homograft mice, treatment with FKA‐A NPs and PTX‐A NPs significantly suppressed the growth of homograft tumor compared with PTX‐A NPs but did not decrease mice's body weight. In summary, we demonstrate that FKA‐A NPs enhance the efficacy of PTX‐A NPs against OCs in vitro and in vivo via reducing Skp2 expression, thus suppressing YAP nuclear translocation and activity of its target genes.

[1]  Shuying Yang,et al.  Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway , 2022, Cells.

[2]  H. Asadzadeh Aghdaei,et al.  Oncogenic Role of Connective Tissue Growth Factor Is Associated with Canonical TGF-β Cascade in Colorectal Cancer , 2022, Genes.

[3]  Leiqiang Han,et al.  Inflammatory molecules facilitate the development of docetaxel‐resistant prostate cancer cells in vitro and in vivo , 2022, Fundamental & clinical pharmacology.

[4]  E. Arefian,et al.  Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation , 2022, Cells.

[5]  M. Paquet,et al.  Statins downregulate YAP and TAZ and exert anti-cancer effects in canine mammary tumor cells. , 2021, Veterinary and comparative oncology.

[6]  E. Maiello,et al.  Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives , 2021, Cancers.

[7]  Yi-ming Li,et al.  Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation , 2021, Cell Death & Disease.

[8]  Yan Wang,et al.  Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide , 2021, Journal of cellular and molecular medicine.

[9]  Z. Ji,et al.  Bladder mesenchymal stromal cell-derived exosomal miRNA-217 modulates bladder cancer cell survival through Hippo-YAP pathway , 2021, Inflammation Research.

[10]  Zhen-ning Wang,et al.  Inhibitors Targeting YAP in Gastric Cancer: Current Status and Future Perspectives , 2021, Drug design, development and therapy.

[11]  Xinsheng Gu,et al.  Emerging Roles of SKP2 in Cancer Drug Resistance , 2021, Cells.

[12]  J. Chi,et al.  The Hippo Pathway Effector YAP Promotes Ferroptosis via the E3 Ligase SKP2 , 2021, Molecular Cancer Research.

[13]  Ying-Jie Hu,et al.  Lappaol F, an anticancer agent, inhibits YAP via transcriptional and post-translational regulation , 2021, Pharmaceutical biology.

[14]  Juan Li,et al.  Synergistic Combination of Sodium Aescinate-Stabilized, Polymer-Free, Twin-Like Nanoparticles to Reverse Paclitaxel Resistance , 2020, International journal of nanomedicine.

[15]  Jinghang Zhang,et al.  Skp2 Depletion Reduces Tumor-Initiating Properties and Promotes Apoptosis in Synovial Sarcoma , 2020, Translational oncology.

[16]  D. Zheng,et al.  Down-regulation of Skp2 expression inhibits invasion and lung metastasis in osteosarcoma , 2018, Scientific Reports.

[17]  J. Prat,et al.  Ovarian carcinomas: at least five different diseases with distinct histological features and molecular genetics. , 2018, Human pathology.

[18]  Li Ma,et al.  SKP2- and OTUD1-regulated non-proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity , 2018, Nature Communications.

[19]  Wen-ying Lee,et al.  Panobinostat sensitizes KRAS‐mutant non‐small‐cell lung cancer to gefitinib by targeting TAZ , 2017, International journal of cancer.

[20]  D. Lim,et al.  Mechanical cue‐induced YAP instructs Skp2‐dependent cell cycle exit and oncogenic signaling , 2017, The EMBO journal.

[21]  Chunli Wu,et al.  Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to Herceptin , 2017, Molecules.

[22]  Jing Yang,et al.  Epithelial–mesenchymal transition in tumor metastasis , 2016, Molecular oncology.

[23]  Jing Wang,et al.  Verteporfin can Reverse the Paclitaxel Resistance Induced by YAP Over-Expression in HCT-8/T Cells without Photoactivation through Inhibiting YAP Expression , 2016, Cellular Physiology and Biochemistry.

[24]  Valerie M. Weaver,et al.  Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors , 2015, Molecular biology of the cell.

[25]  D. Mercola,et al.  Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model , 2015, Oncotarget.

[26]  J. George,et al.  The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene , 2011, Oncogene.

[27]  S. Orsulic,et al.  Ovarian Cancer , 1993, British Journal of Cancer.

[28]  Gui-Bin Xue,et al.  Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis. , 2018, Biochemical and biophysical research communications.